Cytosorbents (CTSO) Competitors $0.92 -0.02 (-2.47%) Closing price 04:00 PM EasternExtended Trading$0.92 +0.00 (+0.29%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTSO vs. MGRM, SI, INGN, STIM, NNOX, INFU, CVRX, ELMD, NYXH, and SGHTShould you be buying Cytosorbents stock or one of its competitors? The main competitors of Cytosorbents include Monogram Orthopaedics (MGRM), Shoulder Innovations (SI), Inogen (INGN), Neuronetics (STIM), Nano-X Imaging (NNOX), InfuSystem (INFU), CVRx (CVRX), Electromed (ELMD), Nyxoah (NYXH), and Sight Sciences (SGHT). These companies are all part of the "medical equipment" industry. Cytosorbents vs. Its Competitors Monogram Orthopaedics Shoulder Innovations Inogen Neuronetics Nano-X Imaging InfuSystem CVRx Electromed Nyxoah Sight Sciences Cytosorbents (NASDAQ:CTSO) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings. Which has more risk & volatility, CTSO or MGRM? Cytosorbents has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Do analysts rate CTSO or MGRM? Cytosorbents presently has a consensus target price of $5.50, suggesting a potential upside of 500.90%. Monogram Orthopaedics has a consensus target price of $5.40, suggesting a potential downside of 6.09%. Given Cytosorbents' higher probable upside, equities analysts plainly believe Cytosorbents is more favorable than Monogram Orthopaedics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cytosorbents 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Is CTSO or MGRM more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to Cytosorbents' net margin of -25.58%. Cytosorbents' return on equity of -111.97% beat Monogram Orthopaedics' return on equity.Company Net Margins Return on Equity Return on Assets Cytosorbents-25.58% -111.97% -29.00% Monogram Orthopaedics N/A -126.82%-96.87% Do insiders and institutionals hold more shares of CTSO or MGRM? 32.9% of Cytosorbents shares are owned by institutional investors. Comparatively, 0.5% of Monogram Orthopaedics shares are owned by institutional investors. 6.6% of Cytosorbents shares are owned by insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has higher earnings & valuation, CTSO or MGRM? Monogram Orthopaedics has lower revenue, but higher earnings than Cytosorbents. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Cytosorbents, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCytosorbents$35.60M1.61-$20.72M-$0.17-5.38Monogram Orthopaedics$370K631.41-$16.33M-$0.50-11.50 Does the media favor CTSO or MGRM? In the previous week, Monogram Orthopaedics had 1 more articles in the media than Cytosorbents. MarketBeat recorded 2 mentions for Monogram Orthopaedics and 1 mentions for Cytosorbents. Monogram Orthopaedics' average media sentiment score of 1.45 beat Cytosorbents' score of 1.15 indicating that Monogram Orthopaedics is being referred to more favorably in the news media. Company Overall Sentiment Cytosorbents Positive Monogram Orthopaedics Positive SummaryCytosorbents and Monogram Orthopaedics tied by winning 8 of the 16 factors compared between the two stocks. Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTSO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTSO vs. The Competition Export to ExcelMetricCytosorbentsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$58.90M$10.84B$5.78B$10.19BDividend YieldN/A1.86%5.73%4.61%P/E Ratio-5.3820.5674.8626.40Price / Sales1.6130.45543.78125.99Price / CashN/A25.0025.8129.91Price / Book4.583.4313.256.28Net Income-$20.72M$210.63M$3.29B$270.38M7 Day Performance-6.83%-0.87%0.47%2.70%1 Month Performance-21.09%1.65%4.60%5.99%1 Year Performance-15.25%-11.60%73.42%25.94% Cytosorbents Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTSOCytosorbents2.5186 of 5 stars$0.92-2.5%$5.50+500.9%-13.1%$58.90M$35.60M-5.38220Positive NewsMGRMMonogram Orthopaedics1.7801 of 5 stars$5.75+0.7%$5.40-6.1%+75.3%$232.01MN/A-11.5028Short Interest ↓SIShoulder Innovations3.3305 of 5 stars$16.03+7.9%$19.60+22.3%N/A$226.14MN/A-0.5461News CoverageAnalyst UpgradeINGNInogen4.0987 of 5 stars$8.45+4.2%$11.00+30.2%-24.6%$219.29M$343.47M-7.971,030STIMNeuronetics2.0262 of 5 stars$3.37+4.3%$7.00+107.7%+328.2%$213.58M$74.89M-2.98180Positive NewsNNOXNano-X Imaging2.9691 of 5 stars$4.02+8.9%$8.50+111.4%-38.3%$213.21M$11.28M-4.47190INFUInfuSystem3.1113 of 5 stars$10.26+1.0%$12.50+21.8%+53.5%$209.57M$139.89M171.03410Positive NewsCVRXCVRx2.7347 of 5 stars$7.95+1.7%$14.00+76.1%+0.3%$204.51M$51.29M-3.79160News CoveragePositive NewsELMDElectromed3.993 of 5 stars$24.96+2.0%$36.25+45.2%+31.0%$204.31M$64M33.28160News CoverageInsider TradeNYXHNyxoah3.1766 of 5 stars$5.84-1.5%$15.00+156.8%-33.2%$201.98M$4.89M-2.54110SGHTSight Sciences3.564 of 5 stars$3.69flat$4.42+19.7%-50.2%$193.24M$79.87M-3.84210News CoverageAnalyst Upgrade Related Companies and Tools Related Companies MGRM Competitors SI Competitors INGN Competitors STIM Competitors NNOX Competitors INFU Competitors CVRX Competitors ELMD Competitors NYXH Competitors SGHT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTSO) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytosorbents With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTSO Stock Alerts